Multitargeting Prodrugs that Release Oxaliplatin, Doxorubicin and Gemcitabine are Potent Inhibitors of Tumor Growth and Effective Inducers of Immunogenic Cell Death
Open Access
- 11 September 2023
- journal article
- research article
- Published by Wiley in Angewandte Chemie
- Vol. 135 (42)
Abstract
A multitargeting prodrug (2) that releases gemcitabine, oxaliplatin, and doxorubicin in their active form in cancer cells is a potent cytotoxic agent with nM IC50s; it is highly selective to cancer cells with mean selectivity indices to human (136) and murine (320) cancer cells. It effectively induces release of DAMPs (CALR, ATP & HMGB1) in CT26 cells facilitating more efficient phagocytosis by J774 macrophages than the FDA drugs or their co‐administration. The viability of CT26 cells co‐cultured with J774 macrophages and treated with 2 was reduced by 32 % compared to the non‐treated cells, suggesting a synergistic antiproliferative effect between the chemical and immune reactions. 2 inhibited in vivo tumor growth in two murine models (LLC and CT26) better than the FDA drugs or their co‐administration with significantly lower body weight loss. Mice inoculated with CT26 cells treated with 2 showed slightly better tumor free survival than doxorubicin.Keywords
Funding Information
- Israel Science Foundation (1002/18)
- Grantová Agentura České Republiky (23-06307S)
This publication has 45 references indexed in Scilit:
- Platinum(IV) complexes as inhibitors of CD47-SIRPα axis for chemoimmunotherapy of cancerEuropean Journal of Medicinal Chemistry, 2022
- PlatinER: A Highly Potent Anticancer Platinum(II) Complex that Induces Endoplasmic Reticulum Stress Driven Immunogenic Cell DeathAngewandte Chemie International Edition, 2020
- Expanding the Arsenal of PtIV Anticancer Agents: Multi‐action PtIV Anticancer Agents with Bioactive Ligands Possessing a Hydroxy Functional GroupAngewandte Chemie International Edition, 2019
- Cytokines in immunogenic cell death: Applications for cancer immunotherapyCytokine, 2017
- Induction of Immunogenic Cell Death by Chemotherapeutic Platinum ComplexesAngewandte Chemie International Edition, 2015
- Cisplatin in cancer therapy: Molecular mechanisms of actionEuropean Journal of Pharmacology, 2014
- Inducers of immunogenic cancer cell deathCytokine & Growth Factor Reviews, 2013
- Hallmarks of Cancer: The Next GenerationCell, 2011
- Kinetic Cell-Based Morphological Screening: Prediction of Mechanism of Compound Action and Off-Target EffectsChemistry & Biology, 2009
- Multi-target therapeutics: when the whole is greater than the sum of the partsDrug Discovery Today, 2007